Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,408 | 154,901 | 150,072 | 141,139 | 132,953 |
| Marketable Securities | 239,933 | 236,949 | 241,402 | 229,063 | 217,617 |
| Receivables | 225,353 | 204,494 | 204,701 | 212,229 | 212,072 |
| Inventories | 172,183 | 158,034 | 168,468 | 175,688 | 183,759 |
| Other current assets | 80,711 | 91,206 | 63,457 | 62,991 | 62,605 |
| TOTAL | $878,588 | $845,584 | $828,100 | $821,110 | $809,006 |
| Non-Current Assets | |||||
| PPE Net | 361,233 | 357,422 | 349,664 | 347,161 | 343,010 |
| Intangibles | 226,287 | 46,155 | 228,518 | 230,386 | 235,198 |
| Other Non-Current Assets | 105,983 | 281,543 | 94,088 | 90,584 | 91,433 |
| TOTAL | $693,503 | $685,120 | $672,270 | $668,131 | $669,641 |
| Total Assets | $1,572,091 | $1,530,704 | $1,500,370 | $1,489,241 | $1,478,647 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62,249 | 60,057 | 44,127 | 50,085 | 52,458 |
| Accrued Expenses | 174,763 | 236,131 | 202,074 | 188,842 | 178,267 |
| TOTAL | $936,077 | $934,568 | $760,208 | $822,776 | $878,668 |
| Non-Current Liabilities | |||||
| Long Term Debt | 594,868 | 593,110 | 630,011 | 597,958 | 600,021 |
| Deferred Revenues | 28,065 | 27,380 | 26,007 | 25,849 | 25,943 |
| Other Non-Current Liabilities | 41,981 | 38,935 | 34,597 | 30,324 | 30,355 |
| TOTAL | $709,926 | $704,349 | $685,176 | $674,963 | $673,766 |
| Total Liabilities | $1,646,003 | $1,638,917 | $1,445,384 | $1,497,739 | $1,552,434 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,123 | 88,005 | 89,658 | 89,541 | 89,531 |
| Common Shares | 10,374 | 10,334 | 10,312 | 10,283 | 10,255 |
| Retained earnings | 609,420 | 540,401 | 488,033 | 431,577 | 364,375 |
| Other shareholders' equity | -32,853 | -37,843 | -29,658 | -29,718 | -32,360 |
| TOTAL | $-73,912 | $-108,213 | $54,986 | $-8,498 | $-73,787 |
| Total Liabilities And Equity | $1,572,091 | $1,530,704 | $1,500,370 | $1,489,241 | $1,478,647 |